Andree Rothermel, PhDAuthorized Officer and Director Biomarker Development at TRON
Andrée Rothermel has more than 10 years of experience in the development and validation of high-throughput screening technologies for drug and biomarker discovery and scientific project management. He holds a PhD in Biology from the Technische Universität Darmstadt, Germany. In 2008, he qualified as a university lecturer at the Department of Biosciences, Pharmacy and Psychology at Leipzig University. In 2011, he joined the research institute TRON in Mainz as its head of the Biomarker Development Center, where he has also been an authorized officer since 2017. In addition, since 2011 he has led team at BioNTech Diagnostics Mainz, which develops technology platforms for the identification and validation of serological markers. Since 2016 he is also managing director of the Cluster for Individualized Immune Intervention (Ci3) based in Mainz.